Radoslaw Kaczmarek: Challenges Limiting Gene Therapy Use in Hemophilia
Radoslaw Kaczmarek, Researcher at IU School of Medicine and Hirszfeld Institute, shared an insightful review on X, reposting from The Video Journal of Hematology and Hematological Oncology:
”Thank you for having me The Video Journal of Hematology and Hematological Oncology.
Several colleagues and I also published a reflective article on this:
I summarized some key points in the video.
SPOILER ALERT
It is not due to lack of interest in gene therapy.”
Read the full article here.
Article: Why is the uptake of gene therapy in hemophilia less than expected?
Authors: Glenn F. Pierce, Mark Skinner, Brian O’Mahony, Dawn Rotellini, Radoslaw Kaczmarek
The Video Journal of Hematology and Hematological Oncology shared on X:
”Why has the uptake of gene therapy in hemophilia been less than expected? Is there limited interest in these therapies?
We caught up with Radoslaw Kaczmarek of Indiana University School of Medicine to get the answers to these questions.”
Watch the full interview.
Stay informed on all scientific advances in the field of genetics with Hemostasis Today.
-
Nov 8, 2025, 05:31Phenotyping of Human Platelets by Daisie Yates
-
Nov 8, 2025, 04:35Inaugural Women In Hematology US Focus Meeting 2025 Officially Commenced
-
Nov 7, 2025, 06:59Stephen Cornelissen is Celebrating an Extraordinary Milestone at Australian Red Cross Lifeblood
-
Nov 7, 2025, 06:56Reza Shojaei on Leadership in the Blood and Plasma Sector
-
Nov 7, 2025, 06:52Rachel Margolis-Goodman Announces Groundbreaking Expension of Versiti Blood Research Institute
-
Nov 7, 2025, 06:46What’s New in HIT from THANZ Webinar Series
-
Nov 7, 2025, 03:30Abdallah Othman About Cardiac Vasculature
-
Nov 7, 2025, 03:29Aabha Divya: Thrilled to Share Our Latest Publication in Annals of Thoracic Surgery Short Reports!
-
Nov 7, 2025, 03:28Shantel Holcomb: Boston Scientific is Investing in Innovative Solutions to Improve Outcomes for Patients With CAD